Bairuiji is a biomedical enterprise with independent innovation ability, which provides high-end biomedical products with leading technology to the global market. Its main direction is the research, development, production and sales of biomedical materials, tissue engineering/regenerative medicine and new drug delivery preparations.
The founder of the company brought many years of experience in the United States and international leading technology back to China to independently develop BioRegen? Biomedical technology platform, combined with the research results of a large number of NIH and NSF major funds (* * * about150,000 US dollars) in many American universities for more than ten years, has overcome the unresolved technical and industrialization problems in the industry, made breakthrough progress, and obtained completely independent intellectual property rights. Bioenergy? A number of high-end biomedical products developed by the technology platform have made many important progress, and a number of R&D projects have filled domestic or international gaps, ranking at the international leading or advanced level, breaking the technological monopoly of western developed countries in related fields. The technical achievements have been protected by 5 domestic invention patents and more than 20 international invention patents, and the company has been funded by the Science and Technology Support Plan (Industry) of Jiangsu Science and Technology Department and the National SME Innovation Fund.
In 2009, Bellagio built the first high-standard fully isolated clean production line meeting the requirements of SFDA of China, the European Union and the FDA of the United States, and in the same year, it was licensed by Class II and Class III medical device manufacturers. By the end of 20 1 1, the company has passed ISO 13485, ISO 900 1, and the domestic GMP quality management system certification. 1 products have obtained the US FDA registration certificate, three products have obtained the EU registration certificate, and 1 products have obtained the domestic second class.
Belladji Europe set up a sales center in Beijing 20 1 1. Up to now, the sales network has covered more than 30 provinces and cities across the country. Our company has established long-term cooperative relations in Industry-University-Research with many universities such as Shanghai Jiaotong University, and established cooperative relations with many famous medical institutions at home and abroad, thus realizing BioRegen? Popularization and application of technology.
Changzhou Bairuiji Biomedical Co., Ltd. insists on independent innovation and devotes itself to human health with first-class technology and scientific management. It is the company's goal to provide better treatment plan for patients and improve their health level, and it is the company's unremitting pursuit to become the new hope of patients.
Company contact information: 05 19-88408555
No.0/67, Dongfang East Road, Qishuyan District, Changzhou City
Legal Representative: Shu.
Date of establishment: April 28, 2008
Registered capital: 365,438+0,659,705 yuan.
Location: Jiangsu Province
Unified social credit code: 91320412675465930m.
Operating conditions: In operation.
Industry: manufacturing industry
Company type: limited liability company (Taiwan, Hong Kong and Macao joint venture)
English name: Changzhou Biocon Biopharmaceutical Co., Ltd.
Personnel size: cooperation
Enterprise address: Block B,No. Ye Xue Road 1 17, Xinbei District, Changzhou.
Scope of business: production of three types of 6864 medical and health materials and dressings, and sales of self-produced products; Research and development of biomedicine, medical devices and related products, technology transfer and provision of related technical services; Engaged in cosmetics production (limited to the approved scope of cosmetics production license), sales, commission agency (except auction) and import and export business. (except those involving special state management measures; Projects that must be approved according to law can only carry out business activities after being approved by relevant departments)